Your wellness, well noted.
Every Friday, we distill the week's most important peptide research, longevity science, and wellness intelligence — in plain language, with full citations. No noise. No fluff.
What's Inside
The latest peptide research — BPC-157, GHK-Cu, semaglutide, and beyond — contextualized and translated from journal-speak into plain English.
From senolytics to NAD+ pathways — what the longevity science community is watching, and what it means for your protocols right now.
Longer form breakdowns on topics that deserve more than a paragraph. Dosing frameworks, mechanism explainers, safety reviews.
Subscribers get early access to new WellSourced courses, tools, and content before they go public — including course discounts and beta features.
Typical Issue
3–4 notable studies published this week, with our take on what they actually mean for practitioners and self-experimenters.
A focused breakdown on a single peptide, pathway, or supplement — mechanism, evidence quality, practical application, and caveats.
A practical tip drawn from current research — dosing windows, stacking considerations, reconstitution guides, and timing nuances.
Emerging topics and compounds on our radar — early signal, not settled science. Flagged clearly so you know the evidence level.
Weekly peptide intel, free. Every Friday. Cancel anytime. No spam, no sponsorships driving the editorial.